• 1
    Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007; 297: 813-819.
  • 2
    Bosch FX, de Sanjose S. Chapter 1: human papillomavirus and cervical cancer—burden and assessment of causality. J Natl Cancer Inst Monogr. 2003( 31): 3-13.
  • 3
    Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol. 1995; 33: 2058-2063.
  • 4
    Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56: 1-24.
  • 5
    Recommended immunization schedules for persons aged 0 through 18 years—United States, 2010. MMWR Recomm Rep. 2010; 58: 1-4.
  • 6
    Brookfield KF, Cheung MC, Lucci J, Fleming LE, Koniaris LG. Disparities in survival among women with invasive cervical cancer: a problem of access to care. Cancer. 2009; 115: 166-178.
  • 7
    Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer. 2008; 113( 10 suppl): 2855-2864.
  • 8
    Benard VB, Johnson CJ, Thompson TD, et al. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer. 2008; 113( 10 suppl): 2910-2918.
  • 9
    Conroy K, Rosenthal SL, Zimet GD, et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt). 2009; 18: 1679-1686.
  • 10
    Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008; 43: 239-245.
  • 11
    Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol. 2008; 111: 1103-1110.
  • 12
    Guerry SL, De Rosa CJ, Markowitz LE, et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine. 2011; 29: 2235-2241.
  • 13
    Cook RL, Zhang J, Mullins J, et al. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health. 2010; 47: 596-599.
  • 14
    Brewer NT, Gottlieb SL, Reiter PL, et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011; 38: 197-204.
  • 15
    Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health. 2009; 45: 453-462.
  • 16
    Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010; 171: 357-367.
  • 17
    Gottlieb SL, Brewer NT, Sternberg MR, et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health. 2009; 45: 430-437.
  • 18
    Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine. 2010; 28: 989-995.
  • 19
    National, state, and local area vaccination coverage among adolescents aged 13-17 years—United States, 2009. MMWR Morb Mortal Wkly Rep. 2010; 59: 1018-1023.
  • 20
    Taylor LD, Hariri S, Sternberg M, Dunne EF, Markowitz LE. Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Prev Med 2011; 52: 398-400.
  • 21
    Anhang Price R, Tiro JA, Saraiya M, Meissner HI, Breen N. Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey. Cancer. 2011.
  • 22
    National Center for Health Statistics. 2008 National Health Interview Survey (NHIS) Public Use Data Release: NHIS Survey Description. Accessed December 31, 2009.
  • 23
    Graubard BI, Korn EL. Predictive margins with survey data. Biometrics. 1999; 55: 652-659.
  • 24
    Bach PB. Gardasil: from bench, to bedside, to blunder. Lancet. 2010; 375: 963-964.
  • 25
    Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007; 40: 108-115.
  • 26
    Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007; 45: 107-114.
  • 27
    National, state, and local area vaccination coverage among adolescents aged 13-17 years—United States, 2008. MMWR Morb Mortal Wkly Rep. 2009; 58: 997-1001.
  • 28
    Reiter PL, Cates JR, McRee AL, et al. Statewide HPV vaccine initiation among adolescent females in North Carolina. Sex Transm Dis. 2010; 37: 549-556.
  • 29
    Broder KR, Cohn AC, Schwartz B, et al. Adolescent immunizations and other clinical preventive services: a needle and a hook? Pediatrics. 2008; 121( suppl 1): S25-S34.
  • 30
    Middleman AB, Rosenthal SL, Rickert VI, Neinstein L, Fishbein DB, D'Angelo L. Adolescent immunizations: a position paper of the Society for Adolescent Medicine. J Adolesc Health. 2006; 38: 321-327.
  • 31
    Briss PA, Rodewald LE, Hinman AR, et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med. 2000; 18( 1 suppl): 97-140.
  • 32
    Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal SL, Frazier AL. Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009; 123: 1439-1445.
  • 33
    Marlow LA, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine. 2007; 25: 1945-1952.
  • 34
    Daley MF, Crane LA, Markowitz LE, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics. 2010; 126: 425-433.
  • 35
    Klug SJ, Hukelmann M, Blettner M. Knowledge about infection with human papillomavirus: a systematic review. Prev Med. 2008; 46: 87-98.
  • 36
    Freed GL, Cowan AE, Clark SJ. Primary care physician perspectives on reimbursement for childhood immunizations. Pediatrics. 2008; 122: 1319-1324.
  • 37
    Friedman AL, Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behav. 2007; 34: 471-485.
  • 38
    Smith PJ, Lindley MC, Shefer A, Rodewald LE. Underinsurance and adolescent immunization delivery in the United States. Pediatrics. 2009; 124( suppl 5): S515-S521.
  • 39
    Centers for Disease Control and Prevention (US). Vaccines for Children Program. Accessed April 26, 2010.
  • 40
    Tiro JA, Saraiya M, Jain N, et al. Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer. 2008; 113( 10 suppl): 3013-3030.
  • 41
    Jain N, Singleton JA, Montgomery M, Skalland B. Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006. Public Health Rep. 2009; 124: 642-651.
  • 42
    Montgomery M, Khare M, Wouhib A, Singleton J, Jain N. Assessment of bias in the National Immunization Survey-Teen: benchmarking to the National Health Interview Survey. Abstract presented at: American Association for Public Opinion Research Conference; May 15-18, 2008; New Orleans, Louisiana.
  • 43
    Luman ET, Ryman TK, Sablan M. Estimating vaccination coverage: validity of household-retained vaccination cards and parental recall. Vaccine. 2009; 27: 2534-2539.
  • 44
    Bolton P, Holt E, Ross A, Hughart N, Guyer B. Estimating vaccination coverage using parental recall, vaccination cards, and medical records. Public Health Rep. 1998; 113: 521-526.
  • 45
    Dorell C, Jain N, Yankey D. Validity of parent-reported vaccination status for adolescents aged 13-17 years, National Immunization Survey-Teen, 2008. Public Health Rep. In press.
  • 46
    Neubrand TP, Breitkopf CR, Rupp R, Breitkopf D, Rosenthal SL. Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr (Phila). 2009; 48: 966-969.
  • 47
    Middleman AB. New adolescent vaccination recommendations and how to make them “stick.” Curr Opin Pediatr. 2007; 19: 411-416.